Title 21
PART 312 SUBPART B
Subpart B - Investigational New Drug Application (IND)
- 21 U.S.C. 321, 331, 351, 352, 353, 355, 360bbb, 371; 42 U.S.C. 262.
- 52 FR 8831, Mar. 19, 1987, unless otherwise noted.
21:5.0.1.1.3.2.1.1 | SECTION 312.20 | 312.20 Requirement for an IND. | |
21:5.0.1.1.3.2.1.2 | SECTION 312.21 | 312.21 Phases of an investigation. | |
21:5.0.1.1.3.2.1.3 | SECTION 312.22 | 312.22 General principles of the IND submission. | |
21:5.0.1.1.3.2.1.4 | SECTION 312.23 | 312.23 IND content and format. | |
21:5.0.1.1.3.2.1.5 | SECTION 312.30 | 312.30 Protocol amendments. | |
21:5.0.1.1.3.2.1.6 | SECTION 312.31 | 312.31 Information amendments. | |
21:5.0.1.1.3.2.1.7 | SECTION 312.32 | 312.32 IND safety reporting. | |
21:5.0.1.1.3.2.1.8 | SECTION 312.33 | 312.33 Annual reports. | |
21:5.0.1.1.3.2.1.9 | SECTION 312.38 | 312.38 Withdrawal of an IND. |